ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017
Mar 12, 2018 20:31 pm UTC| Business
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 Conference call and webcast on Tuesday, March 13that 1:30 pm CET/8:30 am EDT Reported positive data from Phase 2b clinical...
Atomera to Showcase its Technology at EDTM 2018
Mar 12, 2018 20:30 pm UTC| Business
LOS GATOS, Calif., March 12, 2018 -- Atomera (NASDAQ:ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today...
Mar 12, 2018 20:30 pm UTC| Business
CLEVELAND, March 12, 2018 -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Bank of America Merrill Lynch...
Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results
Mar 12, 2018 20:30 pm UTC| Business
BUENA, N.J., March 12, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Thursday March 15, 2018 to...
21Vianet Group, Inc. Reports Unaudited Fourth Quarter and Full Year 2017 Financial Results
Mar 12, 2018 20:30 pm UTC| Business
Adjusted EBITDA up 228.9% YoY to RMB171.0 million Adjusted EBITDA margin expanded to 22.3% from 5.8% in prior year period BEIJING, March 12, 2018 -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), a...
Vericel to Host Analyst and Investor Day on April 11, 2018
Mar 12, 2018 20:30 pm UTC| Business
CAMBRIDGE, Mass., March 12, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it will host an Analyst and Investor...
Mar 12, 2018 20:30 pm UTC| Business
WALTHAM, Mass., March 12, 2018 -- Radius Health, Inc. (Nasdaq:RDUS) a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in...